Get the Stockscreener App
288.13
0.09%
-0.275
Bio Rad Laboratories Inc stock is traded at $288.13, with a volume of 24,661.
It is down -0.09% in the last 24 hours and down -5.91% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$287.86
Open:
$285.77
24h Volume:
24,661
Relative Volume:
0.07
Market Cap:
$7.70B
Revenue:
$2.59B
Net Income/Loss:
$168.80M
P/E Ratio:
47.43
EPS:
6.0748
Net Cash Flow:
$357.20M
1W Performance:
+16.78%
1M Performance:
-5.91%
6M Performance:
-9.19%
1Y Performance:
+26.15%
1-Day Range:
$281.86
$290.56
1-Week Range:
$242.79
$290.56
52-Week Range:
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
287.81 | 7.70B | 2.59B | 168.80M | 357.20M | 6.0748 |
ABT
Abbott Laboratories
|
87.84 | 153.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.47 | 123.25B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.76 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.04 | 84.23B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.78 | 47.77B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-07-26 | Downgrade | Citigroup | Buy → Neutral |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Dow Jones Top Company Headlines at 1 AM ET: Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - Moomoo
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN
Bio Rad Laboratories Stock Surges 11% on Reports of Activist Elliott Investment Management Stake - TIKR.com
BIO: Digital PCR growth and quality controls drive performance amid regional and market headwinds - TradingView
BIO: Digital PCR and quality controls drive growth, with margin expansion and efficiency in focus - TradingView
How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership - Sahm
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday - Sahm
Bio-Rad Laboratories (BIO) Stock Soars 13% on Elliott Management Investment News - GuruFocus
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 13.8% Rally? GF Value Says Undervalued - GuruFocus
Why Elliott sees hidden billions inside Bio-Rad Laboratories - MSN
Bio-Rad (BIO) Sees Significant Stock Surge - GuruFocus
Bio-Rad rallies 13.9% as activist stake speculation lifts shares - Quiver Quantitative
BIO Stock Pops As Elliott Targets Turnaround And RBC Sees Upside - timothysykes.com
BIO Stock Jumps As Elliott Activist Stake Meets Bullish RBC Call - StocksToTrade
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories - Benzinga
Nvidia Earnings Could Decide Whether the AI Trade Still Holds - Investing.com
Research Alert: Bio-rad Laboratories Rallies On Wsj Report Of Elliott Management Stake - Moomoo
Bio-Rad (BIO) Sees 10.5% Surge in Stock Value - GuruFocus
Why Is Bio-Rad Laboratories Stock Trending Now - Kalkine Media
Elliott Builds Big Position In Bio-Rad | The Wall Street Journalnewspaper - Magzter
Bio-Rad (BIO) Faces Pressure from Activist Investor Elliott - GuruFocus
Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad -- WSJ - Moomoo
Market Chatter: Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround - Moomoo
Elliott Investment takes stake in Sartorius, Bio-Rad Laboratories By Investing.com - Investing.com Canada
BIO Technical Analysis | Trend, Signals & Chart Patterns | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill
Activist Elliott builds big stake in life-science tools supplier Bio-Rad - MSN
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports - 102.7 WBOW
Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports - Investing.com Nigeria
Elliott Investment Management Takes Stake in Bio-Rad Laboratories (BIO) - GuruFocus
Bio-Rad (BIO) Faces Pressure from Activist Investor - GuruFocus
Elliott Management Takes Stake in Bio-Rad to Boost Stock Performance (BIO) - GuruFocus
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports (BIO:NYSE) - Seeking Alpha
Exclusive | Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - WSJ
Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports By Investing.com - Investing.com South Africa
Elliott Investment Management Has Sizable Stake in Bio-Rad Laboratories, Sources Say -- WSJ - Moomoo
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ - Moomoo
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449 - TradingView
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO - TradingView
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449 - TradingView
Bio-Rad Laboratories Inc (BIO) Stock Price, Quote, News & History - Benzinga
Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says - Moomoo
BIO Reinstated by RBC Capital -- Rating Set to Outperform with $320 Target - GuruFocus
Laboratory Proficiency Testing Market to Witness Massive - openPR.com
BIO Stock Price, Quote & Chart | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill
Bio-Rad (BIO) Receives Outperform Rating from RBC Capital - GuruFocus
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):